Table 1. Bacterial strains and plasmids used in this study.
Relevant characteristicsa | Reference or source | ||||
X. campestris pv. vesicatoria | |||||
85-10 | Pepper-race 2; wild type; Rifr | [51], [73] | |||
85-10ΔhrcQ | hrcQ deletion mutant of strain 85-10 | This study | |||
85-10ΔhrcQ::hrcQ | Derivative of strain 85-10ΔhrcQ carrying hrcQ-c-myc under control of the native promoter inserted into the hpaFG region | This study | |||
85* | 85-10 derivative containing the hrpG* mutation | [34] | |||
85*ΔhrcQ | hrcQ deletion mutant of strain 85* | This study | |||
85*ΔhrcQ::hrcQ | Derivative of strain 85*ΔhrcQ carrying hrcQ-c-myc under control of the native promoter inserted into the hpaFG region | This study | |||
E. coli | |||||
BL21 (DE3) | F- ompT hsdSB (rB - mB -) gal dcm (DE3) | Stratagene, Heidelberg, Germany | |||
Top10 | F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(araleu) 7697 galU galK rpsL (StrR) endA1 nupG | Invitrogen, Karlsruhe, Germany | |||
DH5α | F- recA hsdR17(rk-,mk+) Φ80dlacZ ΔM15 | Bethesda Research Laboratories, Bethesda, Md. | |||
DH5α λpir | F- recA hsdR17(rk-,mk+) Φ80dlacZ ΔM15 [λpir]α | [74] | |||
Plasmids | |||||
pBlueskript(II) KS | Phagemid, pUC derivative; Apr | Stratagene | |||
pBRM | Golden Gate-compatible derivative of pBBR1MCS-5 for lacpromoter-driven gene expression; contains a 3× c-Mycepitope-encoding sequence | [75] | |||
pBRM-P | Derivative of pBRM without lac promoter | This study | |||
pBRMhrcN | pBRM derivative encoding HrcN-c-Myc | [75] | |||
pBRMhrcQ | pBRM derivative encoding HrcQ-c-Myc | This study | |||
pBRMhrcQStop | pBRM derivative encoding HrcQ | This study | |||
pBRM-PhrcQ | pBRM-P derivative containing hrcQ-c-myc and 299 bp upstream region | This study | |||
pBRM-PhrcQStop | pBRM-P derivative containing hrcQ and 299 bp upstream region | This study | |||
pBRMhrcV | pBRM derivative encoding HrcV-c-Myc | N. Hartmann and D. Büttner, unpublished | |||
pBRMhrcV324-645 | pBRM derivative encoding HrcV324-645-c-Myc | N. Hartmann and D. Büttner, unpublished | |||
pBRMxopJ | pBRM derivative encoding XopJ-c-Myc | [26] | |||
pDGW4MhpaA | Derivative of pDGW4M encoding HpaA-c-Myc | [80] | |||
pDMhrcL | Derivative of pDSK602 encoding HrcL-c-Myc | [20] | |||
pGEX-2TKM | GST expression vector; ptac GST lacI q pBR322 ori; Apr, derivative ofpGEX-2TK with polylinker of pDSK604 | Stratagene[38] | |||
pGhpaA | pGEX-2TKM derivative encoding GST-HpaA | [76] | |||
pGhpaB | pGEX-2TKM derivative encoding GST-HpaB | [18] | |||
pGhpaC | pGEX-2TKM derivative encoding GST-HpaC | [18] | |||
pGhrpB2 | pGEX-2TKM derivative encoding GST-HrpB2 | [62] | |||
pGhrpE | pGEX-2TKM derivative encoding GST-HrpE | [55] | |||
pGhrcL | pGEX-2TKM derivative encoding GST-HrcL | [20] | |||
pGhrcN | pGEX-2TKM derivative encoding GST-HrcN | [76] | |||
pGhrcQ | pGEX-2TKM derivative encoding GST-HrcQ | This study | |||
pGhrcU | pGEX-2TKM derivative encoding GST-HrcU | [21] | |||
pGhrcU255-357 | pGEX-2TKM derivative encoding GST-HrcU255-357 | [21] | |||
pGxopA | pGEX-2TKM derivative encoding GST-XopA | [17] | |||
pGxopJ | pGEX-2TKM derivative encoding GST-XopJ | This study | |||
pGxopF1 | pGEX-2TKM derivative encoding GST-XopF1 | [18] | |||
pG300 | pGEX-2TKM derivative encoding GST-AvrBs3 | [77] | |||
pG356F | pGEX-2TKM derivative encoding GST-AvrBs3Δ2 which lacks theN-terminal 152 amino acids | [17] | |||
pGavrBs350 | pGEX-2TKM derivative encoding GST-AvrBs31-50 | [17] | |||
pLAND-P | Derivative of pOK1 carrying fragments of the hpaFG region flanking lacZ, the lac promoter and a triple c-Myc epitope-encoding sequence | This study | |||
pLAND-PhrcQ | Derivative of pLAND-P carrying hrcQ and 299 bp upstream region | This study | |||
pOK1 | Suicide vector; sacB sacQ mobRK2 oriR6K; Smr | [78] | |||
pOKΔhrcQ | Derivative of pOK1 carrying the flanking regions of hrcQ | This study | |||
pRK2013 | ColE1 replicon, TraRK+ Mob+; Kmr | [49] | |||
pUC119 | ColE1 replicon; Apr | [79] |
Ap, ampicillin; Km, kanamycin; Rif, rifampicin; Sm, spectinomycin; Gm, gentamycin; r, resistant.